Fereshteh Zandkarimi
- Cancer Research top 0.5%
- Cancer, Lipids, and Metabolism 10
- Cancer-related molecular mechanisms research 4
- Cancer, Hypoxia, and Metabolism 2
- Pulmonary and Respiratory Medicine top 0.5%
- Ferroptosis and cancer prognosis 14
- Molecular Biology top 2%
- RNA modifications and cancer 10
- Metabolomics and Mass Spectrometry Studies 4
- Mitochondrial Function and Pathology 3
- Oncology top 10%
- Nutrition and Dietetics top 5%
-
- Mass Spectrometry Techniques and Applications 2
- Co-authors
- Brent R. StockwellHuı TanYan ZhangWei GuXuejun JiangHyemin LeeBoyi GanGregory R. Steinberg
- Partner nations
- United StatesJapanCanada
In The Last Decade
Fereshteh Zandkarimi
28 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Cancer Research 2.4k
- Pulmonary and Respiratory Medicine 3.0k
- Molecular Biology 2.7k
- Oncology 425
- Nutrition and Dietetics 197
Countries citing papers authored by Fereshteh Zandkarimi
This map shows the geographic impact of Fereshteh Zandkarimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fereshteh Zandkarimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fereshteh Zandkarimi more than expected).
Fields of papers citing papers by Fereshteh Zandkarimi
This network shows the impact of papers produced by Fereshteh Zandkarimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fereshteh Zandkarimi. The network helps show where Fereshteh Zandkarimi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fereshteh Zandkarimi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 43 | |
| 4 | 2024 | 31 | |
| 5 | 2024 | 19 | |
| 6 | 2024 | 27 | |
| 7 | 2024 | 4 | |
| 8 | Phospholipids with two polyunsaturated fatty acyl tails promote ferroptosisbreakdown → | 2024 | 178 |
| 9 | 2023 | 4 | |
| 10 | 2023 | 20 | |
| 11 | 2023 | 80 | |
| 12 | Identification of essential sites of lipid peroxidation in ferroptosisbreakdown → | 2023 | 253 |
| 13 | 2023 | 8 | |
| 14 | 2023 | 51 | |
| 15 | 2021 | 38 | |
| 16 | Energy-stress-mediated AMPK activation inhibits ferroptosisbreakdown → | 2020 | 851 |
| 17 | 2020 | 216 | |
| 18 | 2019 | 7 | |
| 19 | Imidazole Ketone Erastin Induces Ferroptosis and Slows Tumor Growth in a Mouse Lymphoma Modelbreakdown → | 2019 | 532 |
| 20 | 2014 | 23 |
About Fereshteh Zandkarimi
Fereshteh Zandkarimi is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 29 papers that have together received 4.2k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (14 papers), Cancer, Lipids, and Metabolism (10 papers), RNA modifications and cancer (10 papers), Metabolomics and Mass Spectrometry Studies (4 papers), Cancer-related molecular mechanisms research (4 papers), Mitochondrial Function and Pathology (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Mass Spectrometry Techniques and Applications (2 papers). The work is most often cited by research in Cancer Research (2.4k citations), Pulmonary and Respiratory Medicine (3.0k citations) and Molecular Biology (2.7k citations). Fereshteh Zandkarimi has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Brent R. Stockwell, Huı Tan, Yan Zhang, Wei Gu, Xuejun Jiang, Hyemin Lee, Boyi Gan, Gregory R. Steinberg, Daisuke Nakada and Thomas F. Westbrook.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.